Can you tell me the year keytruda was authorized by the fda for cancer treatment?

What year did the FDA first authorize Keytruda (pembrolizumab) for cancer?

Keytruda (pembrolizumab) was first approved by the FDA in 2014 for the treatment of certain cancers. [1]

What was the first FDA authorization for Keytruda?

The FDA’s initial approval of Keytruda in 2014 was for unresectable or metastatic melanoma that had progressed after prior therapy or for patients who were not eligible for ipilimumab, as reflected in FDA approval coverage. [1]

Are there other “authorized” dates (accelerated approvals, later indications)?

Yes. After the first FDA approval in 2014, Keytruda received additional approvals over subsequent years for new cancer types and specific patient groups, but the first FDA authorization year was still 2014. [1]

Sources

[1] https://www.drugpatentwatch.com/pdp/Keytruda